Artikel ; Online: Nebulization with alkaline hipertonic ibuprofen induces a rapid increase in platelets circulating in COVID-19 patients but not in healthy subjects.
2021 Band 33, Heft 3, Seite(n) 471–478
Abstract: We analyze changes in circulating platelets in COVID-19 positive patients who received conventional treatment Dexamethasone and Enoxaparin (Dexa-Enoxa) compared to patients treated with conventional therapy plus nebulization with alkaline hypertonic ... ...
Abstract | We analyze changes in circulating platelets in COVID-19 positive patients who received conventional treatment Dexamethasone and Enoxaparin (Dexa-Enoxa) compared to patients treated with conventional therapy plus nebulization with alkaline hypertonic ibuprofenate (AHI). Results show that after 24 h of nebulization with AHI, circulating platelets shows an increase about 40% at 24 h and reach 65% at 96 h. In patients with platelets content below 200,000 by microliter the increase was 49% and 79% at 24 and 96 h respectively. In patients with platelets above 200,000 by microliter the increase was 24% and 31% at 24 and 96 h, respectively. The increase of platelets via AHI was similar in both, men and women.To evaluate whether this action of AHI was related to platelets from COVID-19 positive patients or also for healthy people, two controls were included: one of them with 10 healthy volunteers and another one with COVID-19 positive patients hospitalized and treated only with Dexa-Enoxa. Results show that, in healthy volunteers, the number of circulating platelets remains unchanged even after 7 days of treatment with AHI. In COVID-19 positive patients treated only with Dexa-Enoxa for 4 days, platelets increased only 16%. |
|||||
---|---|---|---|---|---|---|
Mesh-Begriff(e) | Adult ; Blood Platelets/metabolism ; COVID-19/blood ; COVID-19/drug therapy ; Enoxaparin/administration & dosage ; Female ; Humans ; Ibuprofen/administration & dosage ; Male ; Middle Aged ; Nebulizers and Vaporizers ; Platelet Count ; SARS-CoV-2/metabolism | |||||
Chemische Substanzen | Enoxaparin ; Ibuprofen (WK2XYI10QM) | |||||
Sprache | Englisch | |||||
Erscheinungsdatum | 2021-08-22 | |||||
Erscheinungsland | England | |||||
Dokumenttyp | Clinical Trial ; Comparative Study ; Journal Article | |||||
ZDB-ID | 1034283-7 | |||||
ISSN | 1369-1635 ; 0953-7104 | |||||
ISSN (online) | 1369-1635 | |||||
ISSN | 0953-7104 | |||||
DOI | 10.1080/09537104.2021.1967918 | |||||
Signatur |
|
|||||
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 2888: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.